Current Suspected Overdose Deaths in Delaware for 2020: Get Help Now!
Help Slow the Spread of Coronavirus. Download DE's New COVID-19 Alert App
The Centers for Disease Control and Prevention is assisting the World Health Organization (WHO) in investigating an outbreak of a severe acute respiratory syndrome of unknown etiology. Cases have been reported in China (Guangdong Province and the Hong Kong Special Administrative Region), Vietnam, Canada, Indonesia, Philippines, Singapore and Thailand. This disease has been characterized by secondary transmission in the health care setting and within households. Most of the identified index cases have traveled to China and a few have had no reported contact with health care workers or sick patients while in China. Approximately 150 cases have been reported. Cases have generally had a brief incubation period (3-5 days). At least two suspect cases have traveled in New York City and Atlanta while symptomatic.
These cases are being reported in the media. Please expect an increase in public inquiries and volume of clinical visits. You should have already received a health alert that includes a CDC press release, an advisory card for travelers returning from affected areas, and an interim advisory for health care workers. This information is available at: http://www.cdc.gov and will be updated periodically.
We have asked clinicians to be alert for patients with onset of illness after February 1, 2003 with:
AND One or more of the following:
We are in the process of developing data collection instruments. Until other options are available, information on these patients should be called to the SARS Domestic Team at 770-488-7100. Questions about specimen collection, preparation and transportation may also be addressed by this team. Clinical consultation is also available at this number from the Clinical Management Team. A more specific telephone number will be available shortly for the investigation teams.
Please include the following information for suspected cases when calling:
In addition to reporting suspected cases, the following clinical specimens should be collected in consultation with CDC: